Market Synopsis
Market Research
Future (MRFR) postulates that the global transfer membrane market size is
projected to reach USD 0.17 billion by 2030 at a healthy CAGR of 2.1% during
the forecast period (2023-2030). Transfer membrane is referred to as the collection of mechanisms which control the
passage of small molecules and ions with the help of biological membranes. The
surging funding by the public and private organizations in terms of life
science research is highly favoring the market growth globally.
Competitive Dashboard
The global transfer
membrane market players are Pall Corporation (Subsidiary of Danaher
Corporation), Santa Cruz Biotechnology, Merck KGaA, GVS, Bio-Rad Laboratories,
Azure Biosystems, PerkinElmer, Axiva
Sichem Biotech, Advansta, Carl Roth, Atto Corporation, Macherey-Nagel, GE
Healthcare, Thermo Fisher Scientific, Abcam, and others.
Market Potential and Pitfalls
Transfer
membrane market is rapidly stealing the limelight during the forecast period
owing to major factors such as augmenting R&D spending by the
biotechnological and pharmaceutical companies, augmenting demand for polyvinylidene
difluoride membrane, and increasing funding in
order to support the clinical researchers. For instance, according to
the Office for National Statistics, the gross domestic expenditure on R&D
was Euro 33.1 billion in 2016 in the U.K.
The transfer
membrane market is expanding at breakneck
speed due to the raising funds for life sciences to target chronic diseases
across the world. Scientific developments in terms of implementation and
introduction of the latest treatment
methods are further estimated to contribute to the global market throughout the
assessment period. Moreover, the increased
funds in R&D of pharmaceutical as well as biotechnological companies are
triggering the demand for transfer membrane across the globe.
On the contrary,
the dearth of skilled professionals in the healthcare sector and the high
availability of alternative methods are some of the top barriers considered to
vitiate the market growth throughout the appraisal period. Despite such
hiccups, the rising demand for a better remedy in terms of pharmaceutical and biological
advancements and a growing number of
target diseases are likely to influence the market growth in the long run.
Global Transfer Membrane Market: Segmental Analysis
The global
transfer membrane market has been segmented
on the basis of transfer method, type, application, and end user.
By mode of type,
the global transfer membrane market has been
segmented into PVDF transfer membranes, nitrocellulose transfer
membranes, and nylon transfer membranes. Among these, the PVDF transfer
membrane is considered to occupy the largest market share owing to its
advantages over nitrocellulose membranes like hydrophobicity and higher
durability, rising proteomic research, and growing R&D activities by the biotechnology
and pharmaceutical companies.
By mode of
transfer method, the global transfer membrane market has been segmented into dry electrotransfer,
semi-dry electrotransfer, tank electrotransfer, and others. Among these, the tank
electrotransfer is predicted to hold the largest share in the market.
By mode of application,
the global transfer membrane market has been
segmented into southern blotting, western blotting, protein sequencing & amino acid analysis, northern blotting, and
others. Among these, the western blotting segment is anticipated to occupy the
largest market share.
By mode of
end-users, the global transfer membrane market has been segmented into diagnostic laboratories, pharmaceutical & biotechnology companies, academic and
research institutes, and others. Among these, the pharmaceutical and biotechnology
companies are estimated to occupy the largest share in the market.
Regional Insights
Geographically,
the transfer
membrane market insights span across regions namely, Europe, America, Asia-Pacific,
and the Middle East & Africa.
Considering the global scenario, the transfer membrane market is dominated by the American region
due to the presence of well-established players. With technological
advancements in the healthcare sector, surging funding by the government in order to support R&D, and growing demand
for transfer methods in this region the market is region is estimated to
propel.
The European
region is estimated to occupy the second position in the global market and is
likely to retain its growth in the long run. The growth is credited to the raising funds in
order to support the preclinical researchers.
The Asia Pacific
region is estimated to experience the fastest growth rate owing to the
expanding proteomics research, the growing
prevalence of target diseases in several economies in this region, and a rising scale of life sciences projects funded
by the private and government bodies.
About US:
Market Research Future (MRFR) enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of Wantstats
Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
